Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Serum-free cryopreservation medium and method for peripheral blood monouclear cells

A technology of peripheral blood mononuclear cells, applied in the field of immune cell cryopreservation, peripheral blood mononuclear cells completely serum-free cryopreservation solution, to maintain cell stability, reduce possibility, and ensure the effect of biological activity

Inactive Publication Date: 2018-10-16
上海韵飞生物科技有限公司
View PDF5 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The purpose of the present invention is to provide a completely serum-free cryopreservation solution for peripheral blood mononuclear cells and its method, to solve the problem of the peripheral blood mononuclear cell cryopreservation solution and cryopreservation solution that can maintain high cell activity and realize long-term storage and immediate recovery. method problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Serum-free cryopreservation medium and method for peripheral blood monouclear cells
  • Serum-free cryopreservation medium and method for peripheral blood monouclear cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1: Preparation of peripheral blood mononuclear cell cryopreservation solution (recombinant human interleukin-2+polyethylene glycol+trehalose+DMEM / F12 medium+human albumin): by volume content, 0.05g / ml human Serum albumin, 50U / mL recombinant human interleukin-2, 0.1g / mL polyethylene glycol, 0.1g / mL trehalose and 99% DMEM / F12 medium were mixed to obtain peripheral blood mononuclear cells Freeze the solution and store it at 4°C for later use.

Embodiment 2

[0037] Embodiment 2: Preparation of peripheral blood mononuclear cell cryopreservation solution (recombinant human interleukin-2+polyethylene glycol+trehalose+DMEM / F12 medium+human albumin): by volume content, 0.05g / ml human Serum albumin, 100 U / mL recombinant human interleukin-2, 0.2 g / mL polyethylene glycol, 0.15 g / mL trehalose and 98% DMEM / F12 medium were mixed to obtain peripheral blood mononuclear cells Freeze the solution and store it at 4°C for later use.

Embodiment 3

[0038] Example 3: Preparation of peripheral blood mononuclear cell cryopreservation solution (recombinant human interleukin-2+polyethylene glycol+trehalose+DMEM / F12 medium+human albumin): by volume content, 1.0g / ml human Serum albumin, 200U / mL recombinant human interleukin-2, 0.0.3g / mL polyethylene glycol, 0.2g / mL trehalose and 95% DMEM / F12 medium were mixed to obtain peripheral blood mononuclear The cell freezing solution was stored at 4°C for later use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a serum-free cryopreservation medium and method for peripheral blood monouclear cells. The serum-free cryopreservation medium comprises recombinant human interleukin-2, humanserum albumin, polyethylene glycol, trehalose and a basic culture medium or sodium chloride for injection. The serum-free cryopreservation medium has the advantages that the recombinant human interleukin-2 (IL-2) is added into the cryopreservation medium, so that the activity stability of immune cells cultured by thawed cells can be increased greatly, the high activity of original cells can be kept, the immune cells can well keep the physiological function and biological feature of the thawed cells, and the problem of direct large-scale amplification of the thawed cells can be solved effectively; the polyethylene glycol and the trehalose are added into the cryopreservation medium, the cryopreservation medium can replace an existing dimethyl sulfoxide-based (DMSO-based) cryopreservation medium, the toxicity of the cryopreservation medium to the cells is lowered effectively, cell stability is maintained, the direct application safety of the thawed cells is increased, and the thawed cellscan be directly used.

Description

technical field [0001] The invention relates to the technical field of cryopreservation of cells, in particular to the cryopreservation of immune cells, especially to the cryopreservation of peripheral blood mononuclear cells, in particular to a complete serum-free cryopreservation solution for peripheral blood mononuclear cells and a method thereof. Background technique [0002] As an effective method to preserve cells, cell cryopreservation has been widely used in the field of biology. Cryopreservation of donor peripheral blood mononuclear cells can maintain their viability and function, which is of great significance for both clinical and basic research, especially when used for the study of a single immune cell. Cryopreservation of peripheral blood mononuclear cells can not only solve the difficulty in collecting peripheral blood mononuclear cells during the induction of existing immune cells, but also require multiple blood collections, and can be used for tumor treatme...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A01N1/02
CPCA01N1/0221
Inventor 陈金卢彬彬陶飞龙唐欢何丽婷程征雁
Owner 上海韵飞生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com